In November 2022, Colorado will vote on the Natural Medicine Health Act, also known as Proposition 122. If passed, this act will legalize possession of psilocybin, ibogaine, DMT, and mescaline. In this article, Martha Hartney provides five key points of commentary on this proposed law.

In 2020, Oregon voters approved Ballot Measure 109, to establish “psilocybin services” within two years. The details of this plan are now available and will soon be implemented.

Martin R. Steele, Chief Executive Officer of Reasons for Hope, writes on behalf of the Veteran Mental Health Leadership coalition to the House Veterans' Affairs Committee to recommend increased funding for psychedelic-assisted therapy for Veteran suicide prevention. They recommend four actions to be taken by the committee.

Sean McAllister responds to Matthew Duffy’s criticism of Colorado’s Natural Medicine Health Act. McAllister cites provisions for grass-roots providers and more egalitarian rules, with low-income people’s access a priority.

Thursday, October 6th, 2022 from 6:00pm-11:00pm MST Mercury Caffe2199 California St.Denver, CO. Register here. Tickets: Sliding scale 25-75 Scholarships Available. Apply Here. The Natural Medicine Health Act (NMHA) is designed to...

Chacruna Institute will be offering three new courses and a workshop which will focus on perspectives such as the Indigenous, scientific, and social justice aspects of psychedelics and sacred plants. This collection of courses and a workshop are the cumulative result of expertise and many years of discussions curated by the Chacruna team.

What was it like to come of age during the psychedelic sixties? Yvonne Negrin recounts her journey from upstate New York to San Francisco.

This article exposes the dark realities of the commercialization and globalization of substances. Indigenous communities in Latinoamerica face an increasing struggle to rightfully access natural resources due to the fight for territory between illicit drug traffickers. Many Indigenous people have lost their lives, and the media has done little to talk about these issues. Diana Negrin gives examples and also explains parallels between these issues and substance problems faced in the U.S.

August 16th – November 29th, 10am-12pm PST/1pm-3pm EST Price $1,100 USD Price $560 for CE credits This course will be composed of a series of independent lectures...

Berra Yazar-Klosinski, Chief Science Officer at the MAPS Public Benefit Corporation, reflects on her journey into psychedelic science.